A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.
Chai Discovery, Noetik, and Boltz have entered multi-year pharma partnerships focused on models, not molecules, hinting at AI’s “infrastructure moment.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback